HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.

Abstract
5-Aminosalicylic acid (5-ASA) is the mainstay of therapy for inflammatory bowel disease (IBD), particularly ulcerative colitis. 5-ASA is the active moiety in sulfasalazine, which was initially developed for the treatment of rheumatoid arthritis more than 60 years ago, by linking 5-ASA with sulfapyridine Because many of the side effects related to sulfasalazine were found to be due to sulfapyridine, several drugs that contain 5-ASA, and lack the side-effect profile of sulfasalazine, have been developed during the last 2 decades. These drugs have proven to be quite effective in treating mild-to-moderate symptoms of IBD, as well as inducing and maintaining remission. Although they exert anti-inflammatory effects, their exact mechanism of action remains elusive. Nonetheless, their success in treating IBD has led to studies using this class of drugs for novel indications. Several recent studies have evaluated the use of 5-ASA drugs (mesalamine) for the treatment of uncomplicated acute diverticulitis. In this review, we will briefly discuss the development of 5-ASA releasing drugs, their metabolism, side effects, indications, mechanisms of action, and the rationale for the clinical use of mesalamine in colonic diverticulitis.
AuthorsHillel D Cohen, Kiron M Das
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 40 Suppl 3 Pg. S150-4 (Aug 2006) ISSN: 0192-0790 [Print] United States
PMID16885699 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Sulfasalazine
  • Mesalamine
Topics
  • Acute Disease
  • Administration, Oral
  • Administration, Rectal
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects, metabolism, therapeutic use)
  • Colitis, Ulcerative (drug therapy)
  • Diverticulitis, Colonic (drug therapy, metabolism)
  • Dose-Response Relationship, Drug
  • Humans
  • Mesalamine (administration & dosage, adverse effects, metabolism, therapeutic use)
  • Sulfasalazine (administration & dosage, adverse effects, metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: